Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07275021 · ClinicalTrials.gov registry record
Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates
A clinical trial of Preterm Less Than 32wks With IVH, WMI/PVL and Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT07275021 is a study of Preterm Less Than 32wks With IVH, WMI/PVL and Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07275021, a study of Preterm Less Than 32wks With IVH, WMI/PVL and Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Cerebral/Cortical Visual Impairment (CVI) is the leading cause of childhood visual impairment in the United States and other industrialized countries. CVI is a brain-based visual disorder in which visual acuity or visual fields are reduced despite a normal eye examination or greater-than-expected visual impairment relative to ocular pathology. CVI is increasingly recognized in children with neurological conditions, yet it often remains undiagnosed until later childhood, delaying opportunities for early intervention. Population-based studies suggest that CVI is more common than previously understood. Recent estimates indicate that over 180,000 individuals in the United States aged 0-22 years may have diagnosed or likely CVI, with only a minority formally identified. Children with CVI frequently have co-occurring neurological conditions, including cerebral palsy, epilepsy, developmental delays, or genetic disorders. Infants born preterm or with conditions such as hypoxic-ischemic encephalopathy (HIE), perinatal stroke, or white matter injury are at particularly high risk. Prospective research also shows that a substantial proportion of infants born very preterm exhibit behavioral features of CVI later in childhood. Despite improvements in neonatal neurocritical care, early detection of CVI remains challenging. Current clinical practice focuses on managing conditions such as HIE, perinatal stroke, periventricular leukomalacia, and other brain injuries, but there is limited research evaluating structured early identification pathways for CVI in infancy. Diagnostic tools such as brain MRI and Visual Evoked Potentials (VEP) have shown potential for identifying brain-based visual dysfunction, but their integration into early predictive models for CVI has not been fully explored. This study addresses a critical gap in pediatric care by prospectively evaluating high-risk neonates using clinical, neuroimaging, neurophysiologic, and standardized developmental assessments th
Conditions Studied
Interventions
- OTHER Prospective Clinical and Neurodevelopmental Data Collection
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital, and Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07275021
The ClinicalTrials.gov registry entry for NCT07275021 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Preterm Less Than 32wks With IVH, WMI/PVL appearing as the primary indexed condition, and to 1 intervention - of which Prospective Clinical and Neurodevelopmental Data Collection is the first listed.
NCT07275021 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07275021 about?
NCT07275021 is a clinical study titled "Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates". Cerebral/Cortical Visual Impairment (CVI) is the leading cause of childhood visual impairment in the United States and other industrialized countries. CVI is a brain-based visual disorder in which visual acuity or visual fields are reduced despite a normal eye examination or greater-than-expected vi...
What is the current status of trial NCT07275021?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-07-07. Estimated completion is 2028-12-31.
What conditions does trial NCT07275021 study?
This clinical trial studies the following conditions: Preterm Less Than 32wks With IVH, WMI/PVL, Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE.
What interventions are being tested in trial NCT07275021?
The interventions under investigation include: Prospective Clinical and Neurodevelopmental Data Collection (OTHER).
Who is sponsoring clinical trial NCT07275021?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07275021 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Preterm Less Than 32wks With IVH, WMI/PVL
All registered trials for this condition
Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.